A Two-Part, Single-Centre, Open (Part A) Single Blind (Part B), Randomised, Placebo-Controlled Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Doses With and Without Food and Multiple Ascending Oral Doses of AZD1305 Extended-Release Tablet in Healthy and Elderly Subjects.

Trial Profile

A Two-Part, Single-Centre, Open (Part A) Single Blind (Part B), Randomised, Placebo-Controlled Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Doses With and Without Food and Multiple Ascending Oral Doses of AZD1305 Extended-Release Tablet in Healthy and Elderly Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2010

At a glance

  • Drugs AZD 1305 (Primary)
  • Indications Arrhythmias
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Dec 2010 Actual end date changed from Aug 2008 to Jul 2008 as reported by ClinicalTrials.gov.
    • 17 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top